Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Florbetapir

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01231971Completed

Alzheimer's Disease Neuroimaging Initiative 2

Showing all 1 trials

Research Network

Common Treatments

  • Florbetapir1
  • Flortaucipir1

Active Sponsors

  • Alzheimer's Therapeutic Research Institute1
  • University of Southern California1
  • National Institute on Aging (NIA)1
  • Northern California Institute of Research and Education1

Top Investigators

Related Conditions

  • Late Mild Cognitive Impairment Lmci1
  • Mild Cognitive Impairment Mci1
  • Alzheimers Disease Ad1
  • Early Mild Cognitive Impairment Emci1

Activity Timeline